Get the Stockscreener App
0.00
100.00%
-0.0035
Geovax Labs Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is also developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; GEO-EM01 for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. GeoVax Labs, Inc. has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.
See More
Previous Close:
$0.0035
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$0.179
Geovax Labs Inc Stock (GOVXW) Company Profile
Name
Geovax Labs Inc
Sector
Industry
Phone
678 384 7220
Address
1900 Lake Park Drive, Suite 380, Smyrna
Compare GOVXW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GOVXW
Geovax Labs Inc
|
0.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Geovax Labs Inc Stock (GOVXW) Latest News
GeoVax’s Next-Generation COVID-19 Vaccine Shows Superior T-Cell Response in CLL Patients, Trial Advances Exclusively – citybuzz - citybuzz
GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients - Yahoo Finance
What drives GeoVax Labs Inc stock priceMarket Breadth Indicators & Buy Sell Timing Alerts - earlytimes.in
Published on: 2025-12-15 02:46:59 - earlytimes.in
New Mpox Variant Emergence Highlights Global Vaccine Supply Vulnerability, GeoVax Accelerates Domestic Alternative – citybuzz - citybuzz
GeoVax Addresses Identification of New Mpox Variant - TradingView — Track All Markets
GeoVax Strengthens Scientific Advisory Board with Global Vaccine Experts - citybuzz
GeoVax Announces Addition of Renowned Global Experts to Its Scientific Advisory Board - Yahoo Finance
GeoVax Secures U.S. Patent for Enhanced Gedeptin Cancer Therapy Through 2045 - citybuzz
GeoVax Announces Issuance of U.S. Patent Covering Enhanced Therapeutic Use of Gedeptin(R) Gene Therapy - Yahoo Finance
GeoVax’s Gedeptin Shows Favorable Safety and Disease Stability in Recurrent Head & Neck Cancer Trial - citybuzz
GeoVax Announces JCO Oncology Advances Publication Highlighting Favorable Safety and Evidence of Disease Stability of Gedeptin(R) in Recurrent Head & Neck Cancer - Yahoo Finance
Insider Sell: How GeoVax Labs Inc stock reacts to bond yieldsJuly 2025 Trends & Weekly Top Performers Watchlists - moha.gov.vn
An analyst sees good growth prospects for Geovax Labs Inc (GOVX) - setenews.com
Can GeoVax Labs Inc. Equity Warrant stock continue upward trendMarket Performance Report & Long-Term Capital Growth Ideas - Newser
Momentum Traders Eye Accord Synergy Limited for Quick BounceValue Traps to Avoid & Exceptional Return Growth - earlytimes.in
What analysts say about GeoVax Labs Inc stockMarket Insider Reports & Low Risk Trading Ideas - earlytimes.in
GeoVax Labs Earnings Call: Vaccine Progress Amid Financial Challenges - MSN
Will GeoVax Labs Inc. stock return to pre crisis levelsQuarterly Portfolio Report & Proven Capital Preservation Methods - Newser
Geovax Labs (GOVX) Stock Analysis Report | Financials & Insights - Benzinga
Update Recap: Why GeoVax Labs Inc. stock appeals to dividend seekersJuly 2025 Macro Moves & Entry Point Confirmation Alerts - moha.gov.vn
GeoVax shareholders approve warrant share issuance and 1-for-10 to 1-for-25 split - Stock Titan
Returns Recap: Will GeoVax Labs Inc. stock outperform Nasdaq indexRate Hike & Reliable Breakout Forecasts - BỘ NỘI VỤ
GeoVax Labs Approves Share Issuance and Reverse Split - TipRanks
GeoVax Labs: Vaccine Progress Amid Financial Challenges - MSN
GeoVax to Present at the Noble Capital Markets Twenty-First Annual Emerging Growth Equity Conference - Yahoo Finance
GeoVax Labs (NASDAQ:GOVX) Price Target Cut to $6.00 by Analysts at D. Boral Capital - Defense World
How resilient is GeoVax Labs Inc. Equity Warrant stock in market downturnsEarnings Recap Report & Fast Gain Stock Trading Tips - newser.com
Should you wait for a breakout in GeoVax Labs Inc. Equity WarrantMarket Volume Report & Expert Curated Trade Setups - newser.com
Can GeoVax Labs Inc. Equity Warrant stock hit analyst price targetsStock Surge & Reliable Price Breakout Signals - newser.com
What technical charts say about GeoVax Labs Inc. stockBreakout Watch & Step-by-Step Swing Trade Plans - newser.com
Why GeoVax Labs Inc. stock is seen as undervaluedWeekly Trade Recap & Free Community Consensus Stock Picks - newser.com
Can GeoVax Labs Inc. stock hit record highs againJuly 2025 Drop Watch & Smart Allocation Stock Reports - newser.com
Relative strength of GeoVax Labs Inc. Equity Warrant in sector analysisPortfolio Value Report & Low Risk High Win Rate Stock Picks - newser.com
Custom watchlist performance reports with GeoVax Labs Inc.Dividend Hike & Safe Capital Growth Stock Tips - newser.com
GeoVax Labs Inc. (GOVX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Combining machine learning predictions for GeoVax Labs Inc. Equity WarrantJuly 2025 Intraday Action & Long-Term Safe Investment Plans - newser.com
Published on: 2025-11-19 17:57:21 - newser.com
How risky is GeoVax Labs Inc. Equity Warrant stock nowWeekly Stock Summary & Technical Confirmation Trade Alerts - newser.com
Real time breakdown of GeoVax Labs Inc. stock performanceQuarterly Portfolio Report & High Accuracy Buy Signal Tips - newser.com
Is now a turning point for GeoVax Labs Inc.July 2025 Trends & Community Consensus Picks - newser.com
Best data tools to analyze GeoVax Labs Inc. Equity Warrant stockWeekly Trade Report & Capital Efficient Trading Techniques - newser.com
Published on: 2025-11-19 13:22:17 - newser.com
D. Boral Capital Maintains GeoVax Labs (GOVX) Buy Recommendation - Nasdaq
Can technical indicators confirm GeoVax Labs Inc. Equity Warrant’s reversalRisk Management & Weekly Top Performers Watchlists - newser.com
GOVX Analyst Update: Price Target Lowered by Jason Kolbert | GOV - GuruFocus
Has GeoVax Labs Inc. found a price floorEntry Point & Precise Buy Zone Identification - newser.com
How to forecast GeoVax Labs Inc. trends using time series2025 EndofYear Setup & Verified Momentum Stock Alerts - newser.com
Published on: 2025-11-19 00:56:36 - newser.com
How GeoVax Labs Inc. Equity Warrant stock benefits from global expansionOptions Play & Weekly Chart Analysis and Guides - newser.com
Tools to monitor GeoVax Labs Inc. Equity Warrant recovery probabilityBuy Signal & Expert Approved Momentum Trade Ideas - newser.com
Geovax Labs Inc Stock (GOVXW) Financials Data
There is no financial data for Geovax Labs Inc (GOVXW). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.36%
1.05%
Cap:
|
Volume (24h):